Mylan Launches Authorized Generic of Ampyra Tablets

HERTFORDSHIRE, England and PITTSBURGH, Sept. 21, 2018 /PRNewswire/ — Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Dalfampridine Extended-Release Tablets, 10 mg, the authorized generic version of Acorda’s Ampyra®, which is indicated to improve walking in adult patients with multiple sclerosis. The launch comes after the United States Court of Appeals for the Federal Circuit upheld the United States District Court … Continue reading “Mylan Launches Authorized Generic of Ampyra Tablets”

Regen BioPharma, Inc. Reports Activation of Immune Cells by Its NR2F6 Small Molecule Inhibitors

SAN DIEGO, September 21, 2018 /PRNewswire/ — Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP), reports its researchers have identified a series of small molecule drugs that inhibit NR2F6 and also activate human immune cells ex-vivo. Evidence provided by studies suggest that NR2F6 represses the body’s immune response against tumors; therefore inhibiting NR2F6 may lead to enhanced … Continue reading “Regen BioPharma, Inc. Reports Activation of Immune Cells by Its NR2F6 Small Molecule Inhibitors”

General Dynamics NASSCO Begins Construction on First Ship in the T-AO Fleet Oiler Program for U.S. Navy

SAN DIEGO, Sept. 21, 2018 /PRNewswire/ — On September 20, 2018, General Dynamics NASSCO, a wholly owned subsidiary of General Dynamics (NYSE: GD), began construction on the future USNS John Lewis (T-AO 205), the first ship for the U.S. Navy’s John Lewis fleet oiler program. Representatives from NASSCO and the U.S. Navy gathered in San Diego for a ceremony to cut the first piece … Continue reading “General Dynamics NASSCO Begins Construction on First Ship in the T-AO Fleet Oiler Program for U.S. Navy”

EXFO delivers active service assurance in Amdocs ONAP enabling real-time orchestrated service lifecycle management

Complete end-to-end service monitoring and testing supporting autonomous workflows with critical service and network KPIs for managing customer experience QUEBEC CITY, Sept. 21, 2018 /PRNewswire/ – EXFO (NASDAQ: EXFO) (TSX: EXF), the communications industry’s test, monitoring and analytics experts, today announced the integration of their active service assurance solution into Amdocs NFV powered by ONAP (Open Network Automation Platform). … Continue reading “EXFO delivers active service assurance in Amdocs ONAP enabling real-time orchestrated service lifecycle management”

CatchMark Declines to Make Firm Offer to Acquire Phaunos Timber Fund Limited

ATLANTA, Sept. 21, 2018 /PRNewswire/ — CatchMark Timber Trust, Inc. (NYSE: CTT) announced today the company has determined not to make an offer to acquire Phaunos Timber Fund Limited (LSE: PTF), a Channel Islands domiciled, closed-end real estate fund.[1] Earlier this month, CatchMark announced a potential offer for Phaunos, which valued Phaunos at $0.57 per share to be paid in … Continue reading “CatchMark Declines to Make Firm Offer to Acquire Phaunos Timber Fund Limited”

Churchill Downs to Construct New Rooftop Lounge Atop Starting Gate Suites

LOUISVILLE, Ky., Sept. 21, 2018 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (“CDI”) (Nasdaq: CHDN), one of the world’s most renowned sports and entertainment venues, will create an elevated experience for guests of the 2019 Kentucky Derby and beyond. The legendary Louisville, Ky. racetrack has announced plans for a $5 million capital investment that will expand … Continue reading “Churchill Downs to Construct New Rooftop Lounge Atop Starting Gate Suites”

Vilacto Bio Unveils Development Programs for LACTOACTIVE iTHER

COPENHAGEN, Denmark, Sept. 21, 2018 (GLOBE NEWSWIRE) — Vilacto Bio Inc. (OTC QB:VIBI) has revealed the initial five areas of development for its new LACTOACTIVE iTHER® compound. LACTOACTIVE iTHER® is a new LACTOACTIVE variant that combines potent immune-system enhancement with a proven nanoparticle drug delivery system. “Our own research suggests, and we firmly believe, that … Continue reading “Vilacto Bio Unveils Development Programs for LACTOACTIVE iTHER”

EDAP TMS SA : EDAP announces Installation of First Focal One HIFU device in South Korea

Successful HIFU Treatments Performed in Seoul National University Bundang Hospital LYON, France, September 20, 2018 — EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the installation of the first Focal One device in South Korea, at the renowned Seoul National University Bundang Hospital (“SNUBH”). Dr. Hakmin Lee, Urologist in SNUBH commented: “We are … Continue reading “EDAP TMS SA : EDAP announces Installation of First Focal One HIFU device in South Korea”

Sorrento Therapeutics Selects OmniComms TrialMaster EDC for Cancer Research

Fort Lauderdale, FL, Sept. 20, 2018 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE),  a clinical stage, antibody-centric, biopharmaceutical company developing new therapies to turn malignant cancers into manageable and possibly curable diseases, has signed a new agreement with OmniComm Systems, Inc. (OTCQX: OMCM), a leading global provider of clinical data management technology. Under the … Continue reading “Sorrento Therapeutics Selects OmniComms TrialMaster EDC for Cancer Research”

The Institute for Basic Science in South Korea Awards Cray Contract to Help Advance Scientific Research

SEATTLE, Sept. 20, 2018 (GLOBE NEWSWIRE) — Global supercomputer leader Cray Inc. (Nasdaq:CRAY) today announced that the Institute for Basic Science (IBS) has awarded the Company a contract valued at $9 million for a Cray® XC50™ supercomputer and Cray® ClusterStor™ L300F storage system. The new supercomputer, paired with the scale-out Lustre® storage solution, will provide high-performance capabilities for IBS to … Continue reading “The Institute for Basic Science in South Korea Awards Cray Contract to Help Advance Scientific Research”